Deep Brain Stimulation (DBS) was invented in the late 1980s, however it was not used to treat depression-resistant patients until Scientific Council Member, Helen Mayberg, M.D. began testing it out in 2003. Her research showed that by using DBS to target a section of the brain that she identified as linked to depression in earlier research ('Brodmann Area 25'), symptoms of...
With the help of a NARSAD Young Investigator Grant, Scientific Council Member Mark S. George, M.D. developed Transcranial Magnetic Stimulation (TMS), a new kind of non-invasive brain stimulation as an alternative for electroconvulsive therapy (ECT) in treatment-resistant depression...
Optogenetics, a new technology invented by Karl Deisseroth, M.D., Ph.D., in 2005 with the help of a NARSAD Young Investigator Grant, gives researchers extraordinary control over specific brain circuits — and with it, new insights into an array of disorders, among them, depression, anxiety and Parkinson’s disease. Optogenetics uses light to make neurons fire one at a time,...
Paola Dazzan, M.D., who leads early psychosis research at the Institute of Psychiatry, King’s College London, has pursued the goal of applying neuroimaging to the study of psychosis with support from three NARSAD Grants. In this most recent...
New study shows breakthrough results for treatment of bipolar disorder and unipolar depression (major depressive disorder) with deep brain stimulation (DBS). The findings show long term abatement of symptoms in treatment-resistant patients. DBS is a groundbreaking option for these...
